share_log
Breakings ·  Sep 30 18:04
MannKind Corp: Announced Top-Level 30-Week Results From Its Phase 4 Inhale-3 Study
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment